Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Registered Address
205 plumstead road, norwich, norfolk, NR1 4AB
Website
-
pharmaco (norfolk) limitedEstimated Valuation
£746.8k
Pomanda estimates the enterprise value of PHARMACO (NORFOLK) LIMITED at £746.8k based on a Turnover of £745.2k and 1x industry multiple (adjusted for size and gross margin).
pharmaco (norfolk) limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of PHARMACO (NORFOLK) LIMITED at £0 based on an EBITDA of £0 and a 4.23x industry multiple (adjusted for size and gross margin).
pharmaco (norfolk) limitedEstimated Valuation
£2.6m
Pomanda estimates the enterprise value of PHARMACO (NORFOLK) LIMITED at £2.6m based on Net Assets of £2.1m and 1.27x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmaco (norfolk) LimitedOverview
Pharmaco (norfolk) Limited is a live company located in norfolk, NR1 4AB with a Companies House number of 08064169. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in May 2012, it's largest shareholder is
harshad hari patel
with a 37.5% stake. Pharmaco (norfolk) Limited is a established,
small sized company, Pomanda has estimated its turnover at
£745.2k with
healthy
growth in recent years.
Pomanda's financial health check has awarded Pharmaco (Norfolk) Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 3 areas for improvement. Company Health Check FAQs
Health Rating1.5out of 5
0 Strong
4 Regular
3 Weak
Size
annual sales of £745.2k, make it smaller than the average company (£18.8m)
£745.2k - Pharmaco (norfolk) Limited
£18.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 8%, show it is growing at a similar rate (9.4%)
8% - Pharmaco (norfolk) Limited
9.4% - Industry AVG
Production
with a gross margin of 34.8%, this company has a comparable cost of product (34.8%)
34.8% - Pharmaco (norfolk) Limited
34.8% - Industry AVG
Profitability
an operating margin of -0.5% make it less profitable than the average company (4.6%)
-0.5% - Pharmaco (norfolk) Limited
4.6% - Industry AVG
Employees
with 4 employees, this is below the industry average (102)
4 - Pharmaco (norfolk) Limited
102 - Industry AVG
Pay Structure
on an average salary of £43k, the company has an equivalent pay structure (£43k)
£43k - Pharmaco (norfolk) Limited
£43k - Industry AVG
Efficiency
resulting in sales per employee of £186.3k, this is equally as efficient (£186.3k)
£186.3k - Pharmaco (norfolk) Limited
£186.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Pharmaco (norfolk) Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Pharmaco (norfolk) Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Pharmaco (norfolk) Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pharmaco (norfolk) Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Pharmaco (norfolk) Limited
- - Industry AVG
PHARMACO (NORFOLK) LIMITED financials
EXPORT
Pharmaco (Norfolk) Limited's latest turnover from November 2023 is estimated at £745.2 thousand and the company has net assets of £2.1 million. According to their latest financial statements, Pharmaco (Norfolk) Limited has 4 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Nov 2023
Nov 2022
Nov 2021
Nov 2020
Jul 2019
Jul 2018
Jul 2017
Jul 2016
Jul 2015
Jul 2014
Jul 2013
Turnover
745,163
686,157
612,323
586,570
609,015
2,164,639
3,343,303
3,122,547
Other Income Or Grants
Cost Of Sales
485,976
446,632
411,818
390,212
403,593
1,473,815
2,291,555
2,155,377
Gross Profit
259,187
239,525
200,504
196,358
205,422
690,824
1,051,748
967,171
Admin Expenses
262,935
243,273
204,252
-1,522,517
209,170
3,749
-89,479
-209,523
723,763
1,097,860
1,008,759
Operating Profit
-3,748
-3,748
-3,748
1,718,875
-3,748
-3,749
89,479
209,523
-32,939
-46,112
-41,588
Interest Payable
21,847
22,721
Interest Receivable
82
162
91
10
Pre-Tax Profit
-3,748
-3,748
-3,748
1,718,875
-3,748
-3,749
67,632
186,884
-32,777
-46,021
-41,578
Tax
-326,586
-12,850
-37,377
Profit After Tax
-3,748
-3,748
-3,748
1,392,289
-3,748
-3,749
54,782
149,507
-32,777
-46,021
-41,578
Dividends Paid
Retained Profit
-3,748
-3,748
-3,748
1,392,289
-3,748
-3,749
54,782
149,507
-32,777
-46,021
-41,578
Employee Costs
172,065
159,964
152,861
147,105
145,868
493,156
745,523
705,206
Number Of Employees
4
4
4
4
4
15
23
22
EBITDA*
1,723,872
-1
93,226
213,271
-29,191
-42,364
-37,840
* Earnings Before Interest, Tax, Depreciation and Amortisation
Nov 2023
Nov 2022
Nov 2021
Nov 2020
Jul 2019
Jul 2018
Jul 2017
Jul 2016
Jul 2015
Jul 2014
Jul 2013
Tangible Assets
144,913
148,661
152,409
156,157
161,154
164,902
168,650
172,397
176,145
179,892
183,640
Intangible Assets
Investments & Other
1,940,448
1,940,448
1,940,448
1,940,448
1,940,448
1,940,448
1,940,448
1,940,448
1,940,448
1,940,448
1,940,448
Debtors (Due After 1 year)
Total Fixed Assets
2,085,361
2,089,109
2,092,857
2,096,605
2,101,602
2,105,350
2,109,098
2,112,845
2,116,593
2,120,340
2,124,088
Stock & work in progress
Trade Debtors
6,504
9,756
13,008
Group Debtors
Misc Debtors
3,252
Cash
96
32,545
32,161
4,153
misc current assets
total current assets
3,348
39,049
41,917
17,161
total assets
2,085,361
2,089,109
2,092,857
2,096,605
2,101,602
2,105,350
2,109,098
2,116,193
2,155,642
2,162,257
2,141,249
Bank overdraft
Bank loan
699,105
Trade Creditors
949,013
1,445,853
1,277,049
Group/Directors Accounts
1,397,286
1,397,286
1,397,285
758,563
other short term finances
hp & lease commitments
other current liabilities
1,494
total current liabilities
1,397,286
1,397,286
1,397,285
1,459,162
949,013
1,445,853
1,277,049
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
699,105
803,903
905,678
provisions
total long term liabilities
699,105
803,903
905,678
total liabilities
1,397,286
1,397,286
1,397,285
1,459,162
1,648,118
2,249,756
2,182,727
net assets
2,085,361
2,089,109
2,092,857
2,096,605
704,316
708,064
711,813
657,031
507,524
-87,499
-41,478
total shareholders funds
2,085,361
2,089,109
2,092,857
2,096,605
704,316
708,064
711,813
657,031
507,524
-87,499
-41,478
Nov 2023
Nov 2022
Nov 2021
Nov 2020
Jul 2019
Jul 2018
Jul 2017
Jul 2016
Jul 2015
Jul 2014
Jul 2013
Operating Activities
Operating Profit
-3,748
-3,748
-3,748
1,718,875
-3,748
-3,749
89,479
209,523
-32,939
-46,112
-41,588
Depreciation
3,748
3,748
3,748
4,997
3,748
3,748
3,747
3,748
3,748
3,748
3,748
Amortisation
Tax
-326,586
-12,850
-37,377
Stock
Debtors
-3,252
-3,252
-3,252
-3,252
13,008
Creditors
-949,013
-496,840
168,804
1,277,049
Accruals and Deferred Income
-1,494
1,494
Deferred Taxes & Provisions
Cash flow from operations
1,397,286
-1
82,134
-768,373
-522,779
129,692
1,226,201
Investing Activities
capital expenditure
-1
-187,388
Change in Investments
1,940,448
cash flow from investments
-1
-2,127,836
Financing Activities
Bank loans
-699,105
699,105
Group/Directors Accounts
-1,397,286
1
638,722
758,563
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
-699,105
-104,798
-101,775
905,678
share issue
627,800
100
interest
-21,847
-22,639
162
91
10
cash flow from financing
-1,397,286
1
-82,230
735,924
523,164
-101,684
905,788
cash and cash equivalents
cash
-96
-32,449
384
28,008
4,153
overdraft
change in cash
-96
-32,449
384
28,008
4,153
pharmaco (norfolk) limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for pharmaco (norfolk) limited. Get real-time insights into pharmaco (norfolk) limited's credit score, group structure and payment trends.
Perform a competitor analysis for pharmaco (norfolk) limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other small companies, companies in NR1 area or any other competitors across 12 key performance metrics.
pharmaco (norfolk) limited Ownership
PHARMACO (NORFOLK) LIMITED group structure
Pharmaco (Norfolk) Limited has 2 subsidiary companies.
The largest shareholders in Pharmaco (Norfolk) Limited include Harshad Hari Patel and Divya Harshad Patel.
harshad hari patel
37.53%
divya harshad patel
37.47%
mitul harshad patel
25%
pharmaco (norfolk) limited directors
Pharmaco (Norfolk) Limited currently has 4 directors.
The longest serving directors include
Mrs Divya Patel (May 2012) and
Mrs Sonali Patel (May 2012).
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
May 2012
age
13
incorporated
UK
ultimate parent company
None
accounts
Total Exemption Full
last accounts submitted
November 2023
previous names
N/A
accountant
-
auditor
-
address
205 plumstead road, norwich, norfolk, NR1 4AB
Bank
-
Legal Advisor
-
pharmaco (norfolk) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pharmaco (norfolk) limited.
pharmaco (norfolk) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PHARMACO (NORFOLK) LIMITED. This can take several minutes, an email will notify you when this has completed.
pharmaco (norfolk) limitedCompanies House Filings - See Documents
